Cargando…
Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”
To guide developers of innovative and generic drug products that contain nanomaterials, the U.S. Food and Drug Administration issued the draft guidance for industry titled: “Drug Products, Including Biological Products, that Contain Nanomaterials” in December 2017. During the AAPS Guidance Forum on...
Autores principales: | de Vlieger, Jon S. B., Crommelin, Daan J. A., Tyner, Katherine, Drummond, Daryl C., Jiang, Wenlei, McNeil, Scott E., Neervannan, Sesha, Crist, Rachael M., Shah, Vinod P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6470106/ https://www.ncbi.nlm.nih.gov/pubmed/30997588 http://dx.doi.org/10.1208/s12248-019-0329-7 |
Ejemplares similares
-
Perspectives on the FDA Draft Guidances for Use of Adipose Tissue
por: Johnson, Martin L., et al.
Publicado: (2017) -
Paxlovid(TM) Information From FDA and Guidance for AES
Members
por: Cokley, Jon A., et al.
Publicado: (2022) -
Management of venous thromboembolism: clinical guidance from the Anticoagulation Forum
por: Ansell, Jack E.
Publicado: (2016) -
Nanomaterial Characterization in Complex Media—Guidance and Application
por: Hachenberger, Yves Uwe, et al.
Publicado: (2023) -
Information Extraction From FDA Drug Labeling to Enhance Product-Specific Guidance Assessment Using Natural Language Processing
por: Shi, Yiwen, et al.
Publicado: (2021)